Dr. Manuj Agarwal, MD

Dr. Agarwal practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Agarwal's NPI, 1316262363, was assigned on April 1, 2010. Dr. Agarwal holds Pennsylvania license MD466047.

Dr. Agarwal's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Agarwal's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Agarwal is also affiliated with Fox Chase Cancer Center. The medical group on file is Capital Health Medical Group. Dmand AI also links Dr. Agarwal to 3 more hospitals, 13 medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Agarwal's licenses on file in 4 states: Pennsylvania, New Jersey, New York and Virginia.

CMS data shows 158 Medicare services from Dr. Agarwal across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $7,930 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 73, with 36% women.

In 2024, Dr. Agarwal wrote 52 Medicare Part D claims for 18 patients. 46% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $69,998 in total drug cost. In 2023, CMS named 178 claims across 4 drugs.

Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Agarwal, published from 2013 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Prostate-Specific Antigen. Dr. Agarwal has published most often in Brachytherapy. Dr. Agarwal's most frequent co-authors are Vivek K. Narayan, MD, Charles Brian Simone, MD and Lova L. Sun, MD.

CMS Open Payments shows 28 general payments to Dr. Agarwal from 11 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 54% of the total. Elekta, Inc. paid the most, $7,834.